Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-24-001135

Options or other derivatives

  • Chief Medical Officer acquired 130,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lang Eric Chief Medical Officer 2024-06-14 Grant or award · Stock Option +130,000 154,223 D: show line 1 in the form
Loading xslF345X05/ownership.xml…